These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6127330)

  • 1. Clinical trials and ischaemic heart disease: can drugs reduce coronary mortality?
    Silke B; Nelson GI; Taylor SH
    Ir Med J; 1982 Aug; 75(8):297-303. PubMed ID: 6127330
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary disease and antihypertensive treatment with beta blockers in older patients].
    Wikstrand J
    Cardiologia; 1984; 29(1-2):129-44. PubMed ID: 6152540
    [No Abstract]   [Full Text] [Related]  

  • 3. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 4. Modern drug treatment--No. 8. Drugs and the prevention of death from myocardial infarction.
    Graham IM
    Ir Med J; 1982 Aug; 75(8):291-6. PubMed ID: 6127329
    [No Abstract]   [Full Text] [Related]  

  • 5. Fourteen-year (1987 to 2000) trends in the attack rates of, therapy for, and mortality from non-ST-elevation acute coronary syndromes in four United States communities.
    Watkins S; Thiemann D; Coresh J; Powe N; Folsom AR; Rosamond W
    Am J Cardiol; 2005 Nov; 96(10):1349-55. PubMed ID: 16275176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of medical therapy on long-term survival in ischemic heart disease].
    Caruzzo C; Sechi A; Monti C; Campagna G; Spinnler MT
    Minerva Cardioangiol; 1984 Dec; 32(12):887-93. PubMed ID: 6152332
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of ongoing trials of beta blockers in the secondary prevention of coronary heart disease.
    Cutler JA
    Circulation; 1983 Jun; 67(6 Pt 2):I62-5. PubMed ID: 6133645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin in coronary heart disease. Comparison of six clinical trials.
    Canner PL
    Isr J Med Sci; 1983 May; 19(5):413-23. PubMed ID: 6345461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
    Ostapiuk FE; Khvoĭnitskiĭ VA
    Sov Med; 1984; (5):87-9. PubMed ID: 6147019
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of pharmacotherapy in secondary prevention of myocardial infarction and death.
    Gorlin R; Fuster V
    Mt Sinai J Med; 1984 Jun; 51(3):229-36. PubMed ID: 6146929
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of medical treatment in the rehabilitation of the coronary patient].
    Perrenoud JJ
    Rev Med Suisse Romande; 1981 Jan; 101(1):45-9. PubMed ID: 6111834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intervention in ischemic heart disease and myocardial infarction. 3. Medical intervention].
    Pedersen A
    Ugeskr Laeger; 1982 Jul; 144(29):2156-64. PubMed ID: 6128809
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in the secondary prevention of coronary heart disease.
    Veverka A; Jolly JL
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):877-89. PubMed ID: 15500433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does antihypertensive treatment reduce the incidence of coronary disease?].
    Hansson L
    Cardiologia; 1984; 29(1-2):19-25. PubMed ID: 6152541
    [No Abstract]   [Full Text] [Related]  

  • 16. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of nadolol in coronary disease].
    Krotkiewski A; Zatorski A; Jarecki M; Ruszkowski J; Szelemetko J
    Pol Tyg Lek; 1980 Jun; 35(22):833-6. PubMed ID: 6106925
    [No Abstract]   [Full Text] [Related]  

  • 18. Pravastatin and coronary heart disease.
    Bloom JM
    N Engl J Med; 1999 Apr; 340(14):1116-7. PubMed ID: 10206831
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiology according to the European and French scales of myocardial infarction. Data of the MONICA project].
    Cambou JP; Ferrières J; Ruidavets JB; Ducimetière P
    Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():13-8. PubMed ID: 8949313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
    Furberg CD; May GS
    Circulation; 1980 Dec; 62(6 Pt 2):V49-52. PubMed ID: 7002352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.